In this work, we focus on two specific breast cancer subtypes, namely triple-negative (TNBC: HR−, HER2−) and Luminal B (HR+, HER2−, grade 2/3) invasive breast cancers. This evidence concerns the gene ERBB2 and invasive breast carcinoma.